Animal Model Market

Global Animal Model Market Outlook for 2024 to 2034

The global animal model market is estimated to garner a revenue of around USD 1,943.3 million in 2024. Animals possess a shorter life cycle, a high genotype resemblance, and are easy to test in laboratories.

As per the animal model demand analysis report, the overall market is predicted to grow at a moderate CAGR of 6% over the next ten years. The report also forecasts the global animal model industry to reach a value of nearly USD 3,476.8 million by the end of this forecast period.

Animal Model Market Trends and Analysis:

• Traditionally, animal models, like humanized mice, are used prominently in biomedical research that helps develop new treatment methods for various diseases. But, now, demand for different species of animals has increased in the healthcare sector as it offers a better understanding of other diseases, along with the efficacy of drugs with regard to many diseases.
• The development of genetically modified animals for preclinical models that are more predictive in being effective is an arduous and time-consuming process. However, recent progress being made in animal studies and researchers applying new experimental approaches to elucidate the biology of specific diseases has curbed this challenge.

Report Attribute	Details
Animal Model Market Revenue (2024)	USD 1,943.3 million
Market Anticipated Forecast Value (2034)	USD 3,476.8 million
Market Projected Growth Rate (2024 to 2034)	6%

Global Animal Model Market Analysis During Historical Period from 2019 to 2023 Compared to Forecast Outlook for 2024 to 2034

In 2019, the net revenue generated by animal model suppliers and service providers was assessed to be around USD 1,425 million. The global animal model market witnessed a growth rate of 6.4% from 2019 to 2023.

During this period, the animal model market had been facing tremendous pressure from animal welfare organizations and activists in various countries. However, the situation has changed drastically since the outbreak of COVID-19. This change in situation was due to animal model testing being central in research towards developing an effective vaccine against novel coronavirus or other pathogens.

Historical Market CAGR (2019 to 2023)	6.4%
Forecasted Market CAGR (2024 to 2034)	6%

The industry also received a significant fillip during this period due to a rapid rise in demand for non-human primates for research into COVID-19 vaccines. This research is expected to continue in the near future, driving the demand for different species for preclinical models.

Opportunities and Challenges for the Global Animal Model Market Growth

Alternatives such as cell cultures, tissue cultures, and computer models are also available. However, animal models are preferred owing to the complexity of the living systems. Significant incidence rates of diseases, along with adverse effects of drugs, have driven the adoption of animal models to ensure the safety of humans. So, the persisting demand for laboratory animals in pharmacological studies is expected to strengthen the market with the expansion of the pharmaceutical sector.

Pharmacological studies, which include target identification & validation, toxicology drug screening & lead optimization & safety screening, have also surged the demand for advanced animal models for preclinical research. For instance, according to the Pharmaceutical Research and Manufacturers of America, biopharmaceutical businesses spent roughly USD 79.6 billion on research and development in the United States in 2018.

Government intervention in academic and research institutions is increasing for the development of standard protocols related to animal models. Researchers utilize animal models for basic research, such as developing new therapeutic strategies to treat human diseases and preclinical analyses of developed drug safety & efficacy. Moreover, continued advances in animal models, the availability of modern healthcare systems, and a considerable increase in demand for modern healthcare facilities are also expected to propel the market to some degree.

One of the major restraints in the adoption of some animal models is the risk of researchers using animal models being susceptible to false analogy, where implications built around assumptions of similarities between animals and humans can potentially lead to an incorrect conclusion.

Country-wise Insights

The table below puts together the CAGRs for a few countries expected to witness a notable increment in their share of the animal model industry. In North American and European countries witness robust growth rates with relevant policies being reformed by the government to spur funding plans related to animal model research. Several animal model solution providers in Asia are also expected to make huge investments in biogenic research which is reflected in the promising growth rates of China and Japan.

Regional Market Comparison	CAGR (2024 to 2034)
United States	6.7%
Germany	8.2%
United Kingdom	6.6%
Japan	4.7%
China	6.1%

USA Animal Model Market Size to Expand at a Moderate Rate

The demand for experimental animals in the United States for in vivo models is predicted to increase 6.7% through the projected years. The United States is likely to be a dominating country in the animal model market because of

• Growth in research and experiment activities by biotech and pharmaceutical firms in the country.
• Rise in CROs' use of animal models in response to the growing number of clinical trials.
• An increased focus on personalized medications and large investments in these studies.

China to Gradually Increase its Supply of Translational Research Models

The market in China holds a significant share of the global market and is likely to maintain its dominance in Asia for laboratory animals for pharmacological studies. Some prominent factors that are expected to drive the China market at 6.1% CAGR through the forecast period include:

• Increase in the number of programs and rising government spending on overall R&D of pharmaceuticals utilizing animal models.
• Greater recognition of mouse clinical trials (MCTs) with genetic variations for estimating outcomes more accurately.
• Chinese animal model suppliers focus on increasing their geographical presence to gain a large market share.

Category-wise Insights

Rats are Still the Champions as Animal Research Models

Based on species, revenue from rat-based animal models is estimated to account for a 37.3% market share in 2024.

Attributes	Details
Top Species Type or Segment	Rats
Market Share in 2024	37.3%

Revenue from the use of rats in animal models is also slated to expand through the forecasted years due to the following reasons:

• Growing adoption of rodent models to study a variety of complicated illnesses.
• Rising demand for rat models in biomedical research to better understand current health challenges.
• Developments in gene-editing techniques are expanding the mice model market size.

Drug Discovery to remain the Primary Application for Animal Testing Models

The development of animal models for drug discovery is expected to account for nearly 54.4% of the market share in 2024.

Attributes	Details
Top Application Type	Drug Discovery and Development
Market Share in 2024	54.4%

A few key factors that are expected to retain the dominance of the drug discovery and development segment through the forecast years include:

• Higher requirement for biomedical research animals for achieving progress in healthcare and medical science is well-proven
• Demand for animal model systems has gained support from international organizations.
• Recent advancements in lab technologies have made disease-specific animal models safe and constructive.

Competitive Landscape

Key animal model system providers are focusing on strategic acquisitions, mergers, collaborations, and partnerships to grow their client base and boost their industrial position. Recent investments by leading companies have created prospects for the market to expand globally.

The market is now highly influenced by technological interventions in software modeling for time and cost efficiency, along with the growing ethical concerns in reducing the number of live animals used for research. Recent key developments in the market include the development of a novel monkey research model using CRISPR technology.

Recent Developments in the Global Animal Model Market

In January 2020, Horizon Discovery Group plc. confirmed a partnership and license deal with Mammoth Biosciences to gain access to Mammoth's unique CRISPR technology. The partnership is expected to make it easier for Horizon to provide a new generation of genetically altered CHO cells to manufacture biotherapeutics such as therapeutic antibodies.

In March 2022, Charles River Laboratories and Hera Biolabs inked a contract for the breeding, marketing, and sales of SRG rats to the world's preclinical research community. Through this deliberate partnership, Hera BioLabs is aiming to expand the geographic reach of its highly immunodeficient rat model.

Key Players Profiled in the Animal Model Market Report

• Charles River Laboratories International, Inc.
• Horizon Discovery Group plc.
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• Genoway SA
• Eurofins Scientific SE
• Crown Bioscience, Inc.
• Envigo CRS SA
• Transposagen Biopharmaceuticals, Inc.

Animal Model Market Report Scope

Attribute	Details
Estimated Market Size (2024)	USD 1,943.3 million
Projected Market Size (2034)	USD 3,476.8 million
Anticipated Growth Rate (2024 to 2034)	6%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	USD million or billion for Value and Units for Volume
Key Regions Covered	North America; Latin America; Europe; Middle East & Africa (MEA); East Asia; South Asia and Oceania
Key Countries Covered	United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa
Key Segments Covered	By Species Type, By Application, By End User, and By Region
Key Companies Profiled	Charles River Laboratories International, Inc.;  Horizon Discovery Group plc.;  The Jackson Laboratory;  Taconic Biosciences, Inc.;  Genoway SA;  Eurofins Scientific SE;  Crown Bioscience, Inc.;  Envigo CRS SA;  Transposagen Biopharmaceuticals, Inc.
Report Coverage	Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing	Available upon Request

Key Segments Covered by Animal Model Industry Survey Report

By Species Type:

• Rats
• Mice
• Guinea Pigs
• Rabbits
• Monkeys
• Dogs
• Pigs
• Cats
• Other Species

By Application:

• Basic and Applied Research
• Drug Discovery and Development
• Other Applications

By End User:

• Academic & Research Institutions
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Other End Users

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia and Pacific
• Middle East and Africa (MEA)

Frequently Asked Questions

What Big is the Global Animal Model Market Currently?

The global animal model market is estimated to be valued at USD 1,943.3 million in 2024.

What is the Growth Outlook of the Animal Model Market?

The global animal model market is to grow at 6% during the forecast period.

What is the projected Value of Animal Model Market by 2033?

The global animal model market is predicted to be valued at USD 3,476.8 million by 2034.

Which Country is the Dominant Share Holder in the Global Animal Model Market?

The United States accounts for over one-fourth revenue share of the global market.

Which Regional Animal Model Market has the Highest Growth Potential?

Germany is predicted to witness an 8.2% CAGR in the adoption of animal models through 2034.